September 18, 2019 C-Path’s Martha A. Brumfield Named Arizona Bioscience Leader of the Year CHANDLER, Ariz., Sept. 18, 2019 — The Arizona Bioindustry Association (AZBio) today announced that Martha A. Brumf
September 13, 2019 Symptoms of Major Depressive Disorder Scale: Performance of a Novel Patient-Reported Symptom Measure
September 3, 2019 The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson’s Disease
August 14, 2019 Conrado et al. 2019 Towards Regulatory Endorsement Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in...
August 12, 2019 C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting Scientist C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting
August 7, 2019 Funded by FDA, C-Path and NORD to Launch Rare Disease Data and Analytics Platform The collaborative project between the organizations will kick off at a launch meeting in September and will aim to r
July 4, 2019 Summary of Torsades de Pointes (TdP) Reports Associated with Intravenous Drug Formulations Containing the Preservative Chlorobutanol
July 2, 2019 C-Path Taps Medical Science Operations Executive Kristen Swingle as Chief Operating Officer TUCSON, Ariz., July 2, 2019 — The Critical Path Institute (C-Path) is pleased to announce that after an extensive
June 25, 2019 Best Practices for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials
